➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Moodys
AstraZeneca
McKesson
Boehringer Ingelheim

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for BQ-123


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug BQ-123?

BQ-123 is an investigational drug.

There have been 14 clinical trials for BQ-123. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2005.

The most common disease conditions in clinical trials are Coronary Artery Disease, Coronary Disease, and Myocardial Ischemia. The leading clinical trial sponsors are Medical University of Vienna, Brigham and Women's Hospital, and University of Edinburgh.

Recent Clinical Trials for BQ-123
TitleSponsorPhase
The Effect of Endothelin and L-Arginine on Racial Differences in VasoconstrictionThe University of Texas at ArlingtonPhase 1
Mechanisms of Cerebrovascular ControlUniversity of Wisconsin, MadisonPhase 1
Contribution of Endothelin-1 to Exercise Intolerance in Heart FailureUniversity of UtahPhase 0

See all BQ-123 clinical trials

Clinical Trial Summary for BQ-123

Top disease conditions for BQ-123
Top clinical trial sponsors for BQ-123

See all BQ-123 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Johnson and Johnson
Mallinckrodt
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.